Skip to main content

Table 1 Baseline characteristics of the study population

From: Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

 

Rabies

100 µg GMZ2 Alum

30 µg GMZ2 CAF01

100 µg GMZ2 CAF01

p value

Number

N = 6

N = 11

N = 07

N = 20

 

Age (years) *

23 [22–33.75]

25 [23–26]

22 [20–25]

22 [19–33]

0.451

Body mass index (kg/m2) #

21.90 (2.74)

23.02 (2.82)

21.78 (1.43)

22.15 (2.04)

0.635

Hemoglobin (g/dl) #

13.73 (1.35)

14.63 (1.31)

13.51 (1.68)

13.84 (1.29)

0.309

White blood cells (cells/µl) *

5.70 [5.3–6.25]

4.90 [4.2–7]

5.30 [4.3–6.7]

5.10 [4.1–6.9]

0.726

Lymphocytes (cells/µl) *

2.17 [1.9–2.3]

2.32 [1.8–2.6]

2.59 [1.8–2.8]

1.74 [1.5–2.5]

0.396

Monocytes (cells/µl) *

0.54 [0.4–0.6]

0.44[0.3–0.6]

0.49 [0.3–0.5]

0.47 [0.3–0.6]

0.507

Neutrophils (cells/µl) *

2.49 [2–2.9]

2.32 [1.2–2.6]

1.82 [1.3–2.5]

1.84 [1.2–2.5]

0.420

Eosinophils (cells/µl) *

0.27 [0.16–0.86]

0.17 [0.11–0.94]

0.61 [0.12–0.91]

0.34 [0.24–0.94]

0.821

Basophils (cells/µl) *

0.03 [0.02–0.08]

0.06 [0.03–0.11]

0.05 [0.02–0.07]

0.05 [0.02–0.06]

 
  1. N  number of subjects
  2. *Median and [Interquartile range], Kruskal–Wallis test
  3. # Mean (Standard Deviation), ANOVA